In vitro, Kinetin riboside induces apoptosis in the CD34+/CD38- AML stem cell fraction and prevents LSC engraftment in NOD/SCID mouse model while sparing HSC fractions [99]. The gene discussed is CD38; the disease is acute myeloid leukemia.